University of Miami
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, University of Miami sits in the top decile of US sponsors by registered trial count (#46 of 15,742 sponsors by registered trial count).
University of Miami: 721 sponsored US clinical trials, 145 recruiting.
University of Miami sponsors 721 registered US clinical trials on ClinicalTrials.gov, 145 of them currently recruiting, and 430 completed. 79 of these trials are in Phase 3-4 (later-stage) and 134 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Prostate Cancer, with 10 trials.
Top-decile sponsor footprint
University of Miami ranks in the top decile of sponsors by registered trial count (#46 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
430 of 515 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (83.5%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
721 total, page 6 of 15
Speed-specific Training and Ultrasound
NCT05513521
Mindfulness and Yoga or Resistance Exercise Training Fpr Parkinson's Patients
NCT05513534
Coronavirus Disease of 2019 (COVID-19) Health Education Initiative for School Safety
NCT06938230
Aromatherapy for Chemotherapy-induced Nausea and Vomiting (CINV)
NCT05319860
SpeakFree Heat and Moisture Exchanger (HME)
NCT05349487
Optimal Protamine Dosing for Heparin Reversal Following Cardiopulmonary Bypass
NCT05426031
Shockwave Therapy and Platelet Rich Plasma for the Treatment of Erectile Dysfunction
NCT05048667
Meloxicam for Pain Management After Total Joint Arthroplasty (TJA)
NCT05291598
LiftActiv B3 in Post Inflammatory Hyperpigmentation (PIHP)
NCT05327361
Mindfulness Training in Special Operations Forces (SOF) Candidates
NCT04703296
Move to Music Video Intervention for ICU Survivors
NCT04977297
Happy Older Latinos Are Active - Cognitive Decline
NCT04791709
PrEP at a Syringe Services Program
NCT04782180
Functional Sucrase Deficiency in Short Bowel Syndrome Patients With Intestinal Failure
NCT04604275
Testing Integrative Smoking Cessation for HIV Patients
NCT05030766
The Effect of Inelastic Compression System on Quality of Life in People With Chronic Venous Insufficiency
NCT05051540
Healthy Caregivers-Healthy Children
NCT05106426
Team-based Virtual Pediatric Cochlear Implant Clinic
NCT05030961
Patient Performance on Virtual Reality Visual Field Devices as Compared to Standard of Care
NCT04994457
Culturally Tailored Nurse Coaching Study for Cancer Symptom Management
NCT04874584
Measuring Mindfulness Application
NCT04589195
A Bioelectric Dressing for Post De-Roofing Treatment of HS
NCT05057429
Sleep Well for Healthy Brain
NCT04583033
Balance Training With tDCS for CAI
NCT04390048
Circuit Training and Retina
NCT05714813
Healthy Juntos Pilot Study
NCT03986190
Expressing Personal Recollections in English or Spanish to Alleviate Traumatic Emotions (Exprésate)
NCT05090839
Adherence to Electrical Glossal In Situ Stimulation for Sleep Apnea (AEGIS Study)
NCT04974515
Manual Ventilation Efficacy With MVG Device
NCT05059366
Onsite vs. Virtual Group Fitness in Overweight/Obese Women
NCT04974476
Motor Plasticity, Intermittent Hypoxia and Sleep Apnea
NCT04017767
OAB and the Microbiome
NCT04831801
Brain Changes in Psoriasis After Secukinumab Treatment
NCT04717466
Patient Satisfaction After Switching to Oral Testosterone Undecanoate
NCT04983940
Spinal Cord Injury Exercise and Nutrition Conceptual Engagement
NCT03495986
The Effect of Upneeq (Oxymetazoline Hydrochloride 0.1%) on Eyelid Position, Eye Redness, and Eye Appearance
NCT04831047
Reducing the Effects of Aging on Cognition With Therapeutic Intervention of an Oral Nutrient (REACTION): A Pilot Trial
NCT04147624
A Behavioral Health Intervention Using Digital Technology in Radiation Therapy for Prostate Cancer Patients
NCT04946214
Recurrent Urinary Tract Infections and the Microbiome
NCT04831840
Evaluation of Values in Perspective (VIP) Program
NCT04879342
Augmented Reality Perioperative Training and Patient Satisfaction
NCT04727697
Mindfulness Training for Small Teams
NCT04210076
PRP for Treatment of Peyronie's Disease
NCT04512287
Remote Care: The Future of Cochlear Implants
NCT04721327
Feasibility and Acceptability Study of My Sleep Our Sleep (MSOS) Program
NCT04712604
CeraVe Diabetes Mellitus
NCT04724967
Implementation of Onsite, Rapid ART Initiation Among People Who Inject Drugs Living With HIV at Syringe Services Program
NCT04650269
Hidradenitis Suppurativa (HS) Tunneling Wounds
NCT04648631
Asthma Academy: Use of Simulation and Telehealth to Empower Family Caregivers
NCT04132297
Ostomy Belt Use Associated Quality of Life
NCT04715893
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 48 |
| Phase 2 | 86 |
| Phase 3 | 18 |
| Phase 4 | 61 |
Therapeutic Areas
What is open in the University of Miami pipeline
145 recruiting of 721 indexed (20% open); 430 completed (60%).
Phase mix: 79 late (III/IV) vs 134 early (I/II) (early-phase heavy).
Top condition: Prostate Cancer (10 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
University of Miami: open-pipeline peers nationwide
Peers matched on 721 registered trials and 20% open enrollment, not the therapeutic-area sidebar.
University of Miami sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 721 trials (± recruiting share)
- Sanofi · 713 trials · 10% recruiting
- The University of Texas Health Science Center, Houston · 732 trials · 20% recruiting
- Icahn School of Medicine at Mount Sinai · 708 trials · 23% recruiting
- Weill Medical College of Cornell University · 701 trials · 18% recruiting
Sponsors near 20% open enrollment (± trial volume)
- University of California, Irvine · 20% recruiting · 368 trials
- Endeavor Health · 20% recruiting · 94 trials
- Acera Surgical · 20% recruiting · 5 trials
- Align Technology · 20% recruiting · 5 trials
Related
What to do with this University of Miami page
721 registered trials is a research-attention snapshot, not an endorsement of University of Miami or any single study.
- 145 of University of Miami's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Prostate Cancer is the condition University of Miami studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Prostate Cancer trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
University of Miami pipeline card: 721 registered trials from official public datasets.Report a data error.